The cyclopeptide moroidin significantly inhibits migration and vasculogenic mimicry (VM) formation and reduces the expression of α-smooth muscle actin and MMP-9 in human GBM cells by blocking the ERK/β-catenin-mediated EMT.159. Here, MMP9 is linked to glioblastoma.